Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID8413 | NA | NA | Serum | 1933.52 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 42.86% ; In Rectal cancer : 19.44% ; Breast cancer: 0%; In normal healthy individuals : 97.2% | 23667664 |
| CancerPDF_ID8414 | NA | NA | Serum | 2210.34 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide Breast cancer: 77%, In lung cancer :78.57% ; In Rectal cancer : 86.11% ; In normal healthy individuals : 97.2%" | 23667664 |
| CancerPDF_ID8415 | NA | NA | Serum | 2933.03 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 81.43% ; In Rectal cancer : 97.22% ; Breast cancer: 89%; In normal healthy individuals : 97% | 23667664 |
| CancerPDF_ID8416 | NA | NA | Serum | 7740.77 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 85.71% ; In Rectal cancer : 97.22% ; Breast cancer: 98%; In normal healthy individuals : 95.2% | 23667664 |
| CancerPDF_ID8417 | NA | NA | Serum | 4617.02 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 88.57% ; In Rectal cancer : 94.44% ; Breast cancer: 93%; In normal healthy individuals : 94.2% | 23667664 |
| CancerPDF_ID8418 | NA | NA | Serum | 4144.83 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 85.71% ; In Rectal cancer : 94.44% ; Breast cancer: 93%; In normal healthy individuals : 92.4% | 23667664 |
| CancerPDF_ID8419 | NA | NA | Serum | 6412.9 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 92.86% ; In Rectal cancer : 97.22% ; Breast cancer: 97%; In normal healthy individuals : 91% | 23667664 |
| CancerPDF_ID8420 | NA | NA | Serum | 3891.63 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 45.71% ; In Rectal cancer : 33.33% ; Breast cancer: 62%; In normal healthy individuals : 88.2% | 23667664 |
| CancerPDF_ID8421 | NA | NA | Serum | 4455.33 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 81.43% ; In Rectal cancer : 88.89% ; Breast cancer: 67%; In normal healthy individuals : 86.2% | 23667664 |
| CancerPDF_ID8422 | NA | NA | Serum | 4269.96 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 72.86% ; In Rectal cancer : 69.44% ; Breast cancer: 78%; In normal healthy individuals : 82.4% | 23667664 |
| CancerPDF_ID8423 | NA | NA | Serum | 8901.56 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 97.14% ; In Rectal cancer : 97.22% ; Breast cancer: 100%; In normal healthy individuals : 81.2% | 23667664 |
| CancerPDF_ID8424 | SSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 5905.24 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 78.57% ; In Rectal cancer : 86.11% ; Breast cancer: 72%; In normal healthy individuals : 80.6% | 23667664 |
| CancerPDF_ID8425 | NA | NA | Serum | 3152.18 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 52.85% ; In Rectal cancer : 61.11% ; Breast cancer: 43%; In normal healthy individuals : 79.8% | 23667664 |
| CancerPDF_ID8426 | NA | NA | Serum | 3212.45 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 62.86% ; In Rectal cancer : 86.11% ; Breast cancer: 72%; In normal healthy individuals : 79.2% | 23667664 |
| CancerPDF_ID8427 | NA | NA | Serum | 2068.72 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 5.71% ; In Rectal cancer : 22.22% ; Breast cancer: 1%; In normal healthy individuals : 78.80% | 23667664 |
| CancerPDF_ID8428 | NA | NA | Serum | 3362.65 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 81.43% ; In Rectal cancer : 91.67% ; Breast cancer: 72%; In normal healthy individuals : 77.4% | 23667664 |
| CancerPDF_ID8429 | NA | NA | Serum | 2266.53 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 58.57% ; In Rectal cancer : 66.67% ; Breast cancer: 70%; In normal healthy individuals : 76.6% | 23667664 |
| CancerPDF_ID8430 | NA | NA | Serum | 8097 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 91.43% ; In Rectal cancer : 86.11% ; Breast cancer: 97%; In normal healthy individuals : 72.2% | 23667664 |
| CancerPDF_ID8431 | NA | NA | Serum | 3434.65 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 84.29% ; In Rectal cancer : 86.11% ; Breast cancer: 77%; In normal healthy individuals :72% | 23667664 |
| CancerPDF_ID8432 | NA | NA | Serum | 3948.85 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 41.43% ; In Rectal cancer : 41.67% ; Breast cancer: 48%; In normal healthy individuals : 71% | 23667664 |
| CancerPDF_ID8433 | NA | NA | Serum | 4130.82 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 42.86% ; In Rectal cancer : 63.89% ; Breast cancer: 49%; In normal healthy individuals : 70.6% | 23667664 |
| CancerPDF_ID8434 | NA | NA | Serum | 2769.85 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 38.57% ; In Rectal cancer : 58.33% ; Breast cancer: 50%; In normal healthy individuals : 70.20% | 23667664 |
| CancerPDF_ID8435 | NA | NA | Serum | 2545.69 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 70% ; In Rectal cancer : 69.44% ; Breast cancer: 59%; In normal healthy individuals : 68% | 23667664 |
| CancerPDF_ID8436 | NA | NA | Serum | 4279.75 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 44.29% ; In Rectal cancer : 33.33% ; Breast cancer: 57%; In normal healthy individuals : 68% | 23667664 |
| CancerPDF_ID8437 | NA | NA | Serum | 1998.39 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In normal healthy individuals : 66.2% | 23667664 |
| CancerPDF_ID8438 | NA | NA | Serum | 3302.32 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 92.86% ; In Rectal cancer : 97.22% ; Breast cancer: 95%; In normal healthy individuals : 65% | 23667664 |
| CancerPDF_ID8439 | NA | NA | Serum | 4626.49 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 30% ; In Rectal cancer : 55.56% ; Breast cancer: 29%; In normal healthy individuals : 64.60% | 23667664 |
| CancerPDF_ID8440 | NA | NA | Serum | 9223.32 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 81.43% ; In Rectal cancer : 75% ; Breast cancer: 70%; In normal healthy individuals : 60.60% | 23667664 |
| CancerPDF_ID8441 | NA | NA | Serum | 2660.78 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 60% ; In Rectal cancer : 88.89% ; Breast cancer: 80%; In normal healthy individuals : 58.20% | 23667664 |
| CancerPDF_ID8442 | NA | NA | Serum | 13780.5 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 52.86% ; In Rectal cancer : 50% ; Breast cancer: 60%; In normal healthy individuals : 58.2% | 23667664 |
| CancerPDF_ID8443 | NA | NA | Serum | 3810.31 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer :35.71% ; In Rectal cancer : 50% ; Breast cancer: 32%; In normal healthy individuals : 57.6% | 23667664 |
| CancerPDF_ID8444 | NA | NA | Serum | 6626.75 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 98.57% ; In Rectal cancer : 97.22% ; Breast cancer: 98%; In normal healthy individuals : 55% | 23667664 |
| CancerPDF_ID8445 | NA | NA | Serum | 4160.55 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 34.29% ; In Rectal cancer : 16.67% ; Breast cancer: 37%; In normal healthy individuals :53.2% | 23667664 |
| CancerPDF_ID8446 | NA | NA | Serum | 6936.01 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 2.86% ; In Rectal cancer : 61.11% ; Breast cancer: 10%; In normal healthy individuals : 52% | 23667664 |
| CancerPDF_ID8447 | NA | NA | Serum | 2012.39 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 75.71% ; In Rectal cancer : 72.22% ; Breast cancer: 87%; In normal healthy individuals :49.4% | 23667664 |
| CancerPDF_ID8448 | NA | NA | Serum | 2597.36 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 11.43% ; In Rectal cancer : 22.22% ; Breast cancer: 59%; In normal healthy individuals : 48.8% | 23667664 |
| CancerPDF_ID8449 | NA | NA | Serum | 3184.7 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 7.14% ; In Rectal cancer : 50% ; Breast cancer: 30%; In normal healthy individuals : 48.4% | 23667664 |
| CancerPDF_ID8450 | NA | NA | Serum | 3872.19 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 42.86% ; In Rectal cancer : 75% ; Breast cancer: 45%; In normal healthy individuals : 48.2% | 23667664 |
| CancerPDF_ID8451 | NA | NA | Serum | 2082.73 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 5.71% ; In Rectal cancer : 19.44% ; Breast cancer: 67%; In normal healthy individuals : 47.2% | 23667664 |
| CancerPDF_ID8452 | NA | NA | Serum | 4786.97 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 51.43% ; In Rectal cancer : 77.78% ; Breast cancer: 58%; In normal healthy individuals : 45.20% | 23667664 |
| CancerPDF_ID8453 | NA | NA | Serum | 6526.74 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide in normal healthy : 45.2% | 23667664 |
| CancerPDF_ID8454 | NA | NA | Serum | 3254.85 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 24.29% ; In Rectal cancer : 44.44% ; Breast cancer: 21%; In normal healthy individuals : 41.8% | 23667664 |
| CancerPDF_ID8455 | NA | NA | Serum | 3316.32 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 92.86% ; In Rectal cancer : 97.22% ; Breast cancer: 95%; In normal healthy individuals : 40.6% | 23667664 |
| CancerPDF_ID8456 | NA | NA | Serum | 2863.06 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 78.57% ; In Rectal cancer : 83.33% ; Breast cancer: 80%; In normal healthy individuals : 39% | 23667664 |
| CancerPDF_ID8457 | NA | NA | Serum | 4207.72 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 25.71% ; In Rectal cancer : 38.89% ; Breast cancer: 26%; In normal healthy individuals : 37.8% | 23667664 |
| CancerPDF_ID8458 | NA | NA | Serum | 4175.84 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 24.29% ; In Rectal cancer : 27.78% ; Breast cancer: 41%; In normal healthy individuals : 37.6% | 23667664 |
| CancerPDF_ID8459 | NA | NA | Serum | 2944.24 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer :44.29% ; In Rectal cancer : 55.56% ; Breast cancer: 37%; In normal healthy individuals : 34.6% | 23667664 |
| CancerPDF_ID8460 | NA | NA | Serum | 3479.93 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 52.86% ; In Rectal cancer : 58.33% ; Breast cancer: 44%; In normal healthy individuals :34.2% | 23667664 |
| CancerPDF_ID8461 | NA | NA | Serum | 1856.94 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide in normal healthy : 32.80% | 23667664 |
| CancerPDF_ID8462 | NA | NA | Serum | 3226.75 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 1.43% ; In Rectal cancer : 2.78% ; Breast cancer: 3%; In normal healthy individuals : 32.6% | 23667664 |
| CancerPDF_ID8463 | NA | NA | Serum | 4342.03 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 40% ; In Rectal cancer : 50% ; Breast cancer: 32%; In normal healthy individuals : 28.8% | 23667664 |
| CancerPDF_ID8464 | NA | NA | Serum | 4121.95 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 14.29% ; In Rectal cancer : 16.67% ; Breast cancer: 15%; In normal healthy individuals : 28.8% | 23667664 |
| CancerPDF_ID8465 | NA | NA | Serum | 4193.63 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 8.57% ; In Rectal cancer : 8.33% ; Breast cancer: 16%; In normal healthy individuals : 28.8% | 23667664 |
| CancerPDF_ID8466 | NA | NA | Serum | 4529.82 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 4.29% ; In Rectal cancer : 41.67% ; Breast cancer: 28%; In normal healthy individuals : 26.2% | 23667664 |
| CancerPDF_ID8467 | NA | NA | Serum | 3241.49 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 88.57% ; In Rectal cancer : 86.11% ; Breast cancer: 83%; In normal healthy individuals : 25.6% | 23667664 |
| CancerPDF_ID8468 | NA | NA | Serum | 2124.16 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 10% ; In Rectal cancer : 11.11% ; Breast cancer: 8%; In normal healthy individuals : 25.6% | 23667664 |
| CancerPDF_ID8469 | NA | NA | Serum | 4237.35 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 0% ; In Rectal cancer : 19.44% ; Breast cancer: 14%; In normal healthy individuals : 25.6% | 23667664 |
| CancerPDF_ID8470 | NA | NA | Serum | 1463.76 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 40% ; In Rectal cancer : 58.33% ; Breast cancer: 26%; In normal healthy individuals :25.20% | 23667664 |
| CancerPDF_ID8471 | NA | NA | Serum | 3274.73 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 21.43% ; In Rectal cancer : 16.67% ; Breast cancer: 23%; In normal healthy individuals : 25% | 23667664 |
| CancerPDF_ID8472 | NA | NA | Serum | 3962.94 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 2.86% ; In Rectal cancer : 8.33% ; Breast cancer:3%; In normal healthy individuals : 24% | 23667664 |
| CancerPDF_ID8473 | NA | NA | Serum | 6836.01 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 57.14% ; In Rectal cancer : 0% ; Breast cancer: 71%; In normal healthy individuals : 23.6% | 23667664 |
| CancerPDF_ID8474 | NA | NA | Serum | 1779.05 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 7.14% ; In Rectal cancer : 27.78% ; Breast cancer: 11%; In normal healthy individuals : 23% | 23667664 |
| CancerPDF_ID8475 | NA | NA | Serum | 5319.96 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide in normal healthy : 23% | 23667664 |
| CancerPDF_ID8476 | NA | NA | Serum | 1947.61 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide in normal healthy : 21.20% | 23667664 |
| CancerPDF_ID8477 | NA | NA | Serum | 2379.64 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 14.20% ; In Rectal cancer : 19.44% ; Breast cancer: 4%; In normal healthy individuals : 20.6% | 23667664 |
| CancerPDF_ID8478 | NA | NA | Serum | 2075.72 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in lung cancer : 97.2% , In normal healthy individuals : 0%" | 23667664 |
| CancerPDF_ID8479 | NA | NA | Serum | 4069 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in lung cancer : 65.7% , In normal healthy individuals : 5.6%" | 23667664 |
| CancerPDF_ID8480 | NA | NA | Serum | 2652 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in lung cancer : 65.7% , In normal healthy individuals : 2.8%" | 23667664 |
| CancerPDF_ID8481 | NA | NA | Serum | 1787.97 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in lung cancer : 55.7% , In normal healthy individuals : 0.6%" | 23667664 |
| CancerPDF_ID8482 | NA | NA | Serum | 1945.03 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide Breast cancer:99%, In lung cancer : 48.57% ; In Rectal cancer : 75% ; In normal healthy individuals : 0.4%" | 23667664 |
| CancerPDF_ID8483 | NA | NA | Serum | 2673.8 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide in lung cancer : 41.42% ; In breast cancer :42%; In normal healthy individuals : 6% | 23667664 |
| CancerPDF_ID8484 | NA | NA | Serum | 2991.23 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide Breast cancer: 29%; In lung cancer : 38.57% ; In Rectal cancer: 38.89%; In normal healthy individuals : 1.8% | 23667664 |
| CancerPDF_ID8485 | NA | NA | Serum | 1349.53 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide in lung cancer : 30% ; In Rectal cancer:58.33%; In normal healthy individuals : 8% | 23667664 |
| CancerPDF_ID8486 | NA | NA | Serum | 5000.21 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide in lung cancer : 30% ; In breast cancer: 37%; In normal healthy individuals : 7% | 23667664 |
| CancerPDF_ID8487 | NA | NA | Serum | 2976.33 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in lungcancer : 28.57% , In normal healthy individuals : 5.4%" | 23667664 |
| CancerPDF_ID8488 | NA | NA | Serum | 5282.44 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer : 66.67% , In normal healthy individuals : 1.2%" | 23667664 |
| CancerPDF_ID8489 | NA | NA | Serum | 4057.96 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer : 58.33% , In normal healthy individuals : 15.6%" | 23667664 |
| CancerPDF_ID8490 | NA | NA | Serum | 1207.29 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer : 52.787% , In normal healthy individuals : 10.6%" | 23667664 |
| CancerPDF_ID8491 | NA | NA | Serum | 4952.82 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer :50% , In normal healthy individuals : 7.2%" | 23667664 |
| CancerPDF_ID8492 | NA | NA | Serum | 2233.27 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer : 44.44% , In normal healthy individuals : 3.2%" | 23667664 |
| CancerPDF_ID8493 | NA | NA | Serum | 7458.63 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer : 41.67% , In normal healthy individuals : 5.2%" | 23667664 |
| CancerPDF_ID8494 | NA | NA | Serum | 2312.22 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer : 36.11% , In normal healthy individuals : 10%" | 23667664 |
| CancerPDF_ID8495 | NA | NA | Serum | 4468.34 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in breast cancer : 95% , In normal healthy individuals : 2.6%" | 23667664 |
| CancerPDF_ID8496 | NA | NA | Serum | 4057.96 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in breast cancer : 68% , In normal healthy individuals :1 5.6%" | 23667664 |
| CancerPDF_ID8497 | NA | NA | Serum | 5291.71 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in breast cancer : 64% , In normal healthy individuals : 0.4%" | 23667664 |
| CancerPDF_ID8498 | NA | NA | Serum | 1787.97 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in breast cancer :60% , In normal healthy individuals : 2%" | 23667664 |
| CancerPDF_ID8499 | NA | NA | Serum | 2726.07 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in breat cancer : 39% , In normal healthy individuals :6.60%" | 23667664 |
| CancerPDF_ID8500 | NA | NA | Serum | 2452.69 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in breast cancer : 28% , In normal healthy individuals : 1.2%" | 23667664 |
| CancerPDF_ID8501 | ADSGEGDFLAEGGGVR | Fibrinogen alpha | Serum | 1535.69 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8502 | DSGEGDFLAEGGGVR | Fibrinogen alpha | Serum | 1464.65 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8503 | SGEGDFLAEGGGVR | Fibrinogen alpha | Serum | 1349.62 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8504 | GEGDFLAEGGGVR | Fibrinogen alpha | Serum | 1262.59 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8505 | EGDFLAEGGGVR | Fibrinogen alpha | Serum | 1205.57 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8506 | GDFLAEGGGVR | Fibrinogen alpha | Serum | 1076.53 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8507 | DFLAEGGGVR | Fibrinogen alpha | Serum | 1019.5 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8508 | DSGEGDFLAEGGGV | Fibrinogen alpha | Serum | 1308.55 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8509 | SGEGDFLAEGGGV | Fibrinogen alpha | Serum | 1193.52 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8510 | GDFLAEGGGV | Fibrinogen alpha | Serum | 920.42 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8511 | DFLAEGGGV | Fibrinogen alpha | Serum | 863.4 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8512 | FLAEGGGV | Fibrinogen alpha | Serum | 748.38 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8513 | FLAEGGG | Fibrinogen alpha | Serum | 649.31 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8514 | DFLAEGG | Fibrinogen alpha | Serum | 707.31 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8515 | NRGDSTFESKSY | Fibrinogen alpha | Serum | 1389.62 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8516 | SSSYSKQFTSSTSYNRGDSTFES | Fibrinogen alpha | Serum | 2552.09 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8517 | SSSYSKQFTSSTSYNRGDSTFESKS | Fibrinogen alpha | Serum | 2767.22 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8518 | SSSYSKQFTSSTSYNRGDSTFESKSY | Fibrinogen alpha | Serum | 2930.28 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8519 | SSSYSKQFTSSTSYNRGDSTFESKSYKM | Fibrinogen alpha | Serum | 3189.42 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8520 | SSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHGTHSTK | Fibrinogen alpha | Serum | 4783.09 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8521 | SSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHGTHSTKRG | Fibrinogen alpha | Serum | 4996.21 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8522 | SSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHEGTHSTKRGHA | Fibrinogen alpha | Serum | 5333.35 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8523 | SSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 5900.7 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8524 | GDSTFESKSYKMADEAGSEADHEGTHSTKRGHA | Fibrinogen alpha | Serum | 3522.53 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8525 | SYKMADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 3238.52 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8526 | SYKMADEAGSEADHEGTHSTKRGHA | Fibrinogen alpha | Serum | 2671.17 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8527 | SYKMADEAGSEADHEGTHSTK | Fibrinogen alpha | Serum | 2249.95 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8528 | SYKMADEAGSEADHEGTHST | Fibrinogen alpha | Serum | 2121.85 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8529 | KMADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 2988.42 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8530 | MADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 2874.34 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8531 | MADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 2860.33 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8532 | MADEAGSEADHEGTHSTKRGHAKSRP | Fibrinogen alpha | Serum | 2761.26 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8533 | MADEAGSEADHEGTHSTKRGHA | Fibrinogen alpha | Serum | 2292.98 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8534 | ADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 2729.29 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8535 | ADEAGSEADHEGTHSTKRGHA | Fibrinogen alpha | Serum | 2161.94 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8536 | DEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 2658.25 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8537 | DEAGSEADHEGTHSTKRGHAKSRP | Fibrinogen alpha | Serum | 2559.18 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8538 | DEAGSEADHEGTHSTKRGHA | Fibrinogen alpha | Serum | 2090.9 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8539 | DEAGSEADHEGTHSTKRGH | Fibrinogen alpha | Serum | 2019.86 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8540 | DEAGSEADHEGTHSTKRG | Fibrinogen alpha | Serum | 1882.8 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8541 | EAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 2543.22 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8542 | GSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha | Serum | 2343.14 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8543 | GSESGIFTNTKESSSHHPGIAEFPSRG | Fibrinogen alpha | Serum | 2815.32 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8544 | SSKITHRIHWESASLLR | Complement C3f | Serum | 2020.1 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8545 | SKITHRIHWE | Complement C3f | Serum | 1305.69 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8546 | SKITHRIHWESASLL | Complement C3f | Serum | 1776.96 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8547 | KITHRIHWESASLL | Complement C3f | Serum | 1689.93 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8548 | THRIHWESASLL | Complement C3f | Serum | 1448.75 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8549 | THRIHWE | Complement C3f | Serum | 977.48 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8550 | HRIHWESASLL | Complement C3f | Serum | 1347.7 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8551 | IHWESASLL | Complement C3f | Serum | 1054.54 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8552 | HWESASLL | Complement C3f | Serum | 941.46 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8553 | HWESASLL | Complement C3f | Serum | 955.48 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8554 | HWESASL | Complement C3f | Serum | 828.38 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8555 | ASHLGLA | Complement C3f | Serum | 667.37 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8556 | SEETKENEGFTVTAEGK | Complement C3f | Serum | 1854.85 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8557 | RNGFKSHALQLNNRQI | Complement C3f | Serum | 1895.02 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8558 | NGFKSHALQLNNR | Complement C3f | Serum | 1497.78 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8559 | SHALQLNN | Complement C3f | Serum | 895.45 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8560 | GLEEELQFSLGSKINVKVGGNSKGTLKVLR | Complement C3f | Serum | 3199.79 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8561 | GLEEELQFSLGSKINVKVGGNSKGTL | Complement C3f | Serum | 2703.44 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8562 | GLEEELQFSLGSKINVKVGGNS | Complement C3f | Serum | 2304.2 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8563 | DDPDAPLQPVTPLQLFEGRRN | Complement C3f | Serum | 2377.2 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8564 | MNFRPGVLSSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 3271.63 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8565 | PGVLSSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 2723.38 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8566 | GVLSSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 2626.33 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8567 | SSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 2357.16 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8568 | QLGLPGPPDVPDHAAYHPFR | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 2183.09 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8569 | QLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 2026.99 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8570 | GLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 1785.85 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8571 | GLPGPPDVPDHA | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 1170.57 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8572 | GLPGPPDVPDH | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 1099.53 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8573 | PGPPDVPDHA | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 1000.46 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8574 | GPPDVPDHA | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 903.41 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8575 | GPPDVPDH | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 832.37 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8576 | NVHSGSTFFKYYLQGAKIPKPEASFSPR | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 3155.62 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8577 | GSEMVVAGKLQDR | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 1388.71 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8578 | AELQEGARQKLHELQEKLSPLGEEMRDRA | Aplipoprotein A-I | Serum | 3374.74 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8579 | QGLLPVLESFKVSFLSALEEYTKKLNTQ | Aplipoprotein A-I | Serum | 3181.73 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8580 | ATEHLSTLSEKAKPALEDL | Aplipoprotein A-I | Serum | 2052.07 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8581 | ISASAEELRQRLAPLAEDVRGNL | Aplipoprotein A-IV | Serum | 2507.35 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8582 | GNTEGLQKSLAELGGHLDQQVEEFR | Aplipoprotein A-IV | Serum | 2754.36 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8583 | KHNLGHGHKHERDQGHGHQ | Kininogen HMW | Serum | 2208.05 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8584 | NLGHGHKHERDQGHGHQ | Kininogen HMW | Serum | 1942.9 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8585 | GHGLGHGHEQQHGLGHGHKF | Kininogen HMW | Serum | 2126.01 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8586 | ALGISPFHEHAEVVFTANDSGPR | Transthyretin | Serum | 2450.2 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8587 | DSGPRRYTIAALLSPYSYSTTAVVTNPKE | Transthyretin | Serum | 3156.61 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8588 | ALLSPYSYSTTAVVTNPKE | Transthyretin | Serum | 2040.04 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8589 | SYSTTAVVTNPKE | Transthyretin | Serum | 1395.69 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8590 | SYSTTAVVTNPKE | Transthyretin | Serum | 1409.7 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8591 | SALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA | Antichymotrypsin | Serum | 4622.49 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8592 | LVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA | Antichymotrypsin | Serum | 4464.42 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8593 | VETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA | Antichymotrypsin | Serum | 4351.33 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8594 | LMIIVPTDTQNIFFMSKVTNPKQA | Antichymotrypsin | Serum | 2735.44 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8595 | IIVPTDTQNIFFMSKVTNPKQA | Antichymotrypsin | Serum | 2491.31 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8596 | LEAIPMSIPPEVKFNKPFVFLMIDQNTKSPLFMGKVVNPTQK | Alpha-1 antitrypsin | Serum | 4772.55 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8597 | SIPPEVKFNKPFVFLMIDQNTKSPLFMGKVVNPTQK | Alpha-1 antitrypsin | Serum | 4118.21 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8598 | LMIDQNTKSPLFMGKVVNPTQK | Alpha-1 antitrypsin | Serum | 2488.32 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8599 | LEEYTKKLNTQ | Proapolipoprotein | Serum | 1365.71 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8600 | SRSGGGGGGGLGSGGSIRSSY | Cytokeratin | Serum | 1811.85 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8601 | SARLNSQRLVFNRPFLMFIVDNNILFLGKVNRP | Protein c inhibitor | Serum | 3888.15 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8602 | SARLNSQRLVFNRPFLMF | Protein c inhibitor | Serum | 2195.18 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8603 | SARLNSQRLVFNRPFLM | Protein c inhibitor | Serum | 2048.11 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8604 | VKVLDAVRGSPAIN | Prealbumin | Serum | 1437.83 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8605 | VVTNPKE | Prealbumin | Serum | 785.43 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8606 | DAHKSEVAHRF | Serum albumin | Serum | 1295.64 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8607 | DAHKSEVAHRFKD | Serum albumin | Serum | 1538.76 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8608 | PNHFRPAGLPEKY | SAA | Serum | 1524.78 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8609 | PITVTVPVEVSRKNPKFMETVAEKALQEYRKKHREE | SP40 | Serum | 4266.29 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8610 | FQKVKEKLKIDS | Apolipoprotein CI | Serum | 1461.86 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |
| CancerPDF_ID8611 | MGRVYDPRA | C1-inhibitor | Serum | 1063.52 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | NA | 23667664 |